6818850609
Peptides Weekly

Advertise on podcast: Peptides Weekly

This podcast has
9 episodes
Language
English
Explicit
No
Date created
2026/10/03
Latest episode
2026/11/12
Average duration
10 min.
Release period
7 days

Description

What peptides are, what the evidence actually shows, and what is approved, investigational or unregulated. Every Thursday: the week in peptide science and regulation, and one peptide explained properly — mechanism, studies, status, risks. Education only; never dosing, sourcing or protocols, and never medical advice. AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production.

Unlock Peptides Weekly podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from Peptides Weekly podcast


Ep 9: Four in 100 GLP-1 stoppers had a heart event or died yearly, double those who continued, in…
2026/11/12
Peptides Weekly Four in 100 GLP-1 stoppers had a heart event or died yearly, double those who continued, in observational records. What You Need to Know: In observational records, about four in 100 people a year who stopped a GLP-1 had a non-fatal heart attack, stroke, or death, roughly double the rate among people who stayed on treatment. That comparison comes from Italian diabetes-clinic data, not from a trial that assigned people to stop. ... Sources: globalnews.ca · timelinedaily.com · wbaltv.com · europepmc.org · medicalxpress.com · www1.racgp.org.au · blogs.bcm.edu · ua.news Chapters: 0:00 Introduction 0:24 Stopping GLP-1 drugs could increase heart attack risk for some, study says 2:03 GLP-1 Weight Loss Drug Side Effects Include Permanent Blindness, Warns FDA 2:50 ERs see surge in GLP-1 side effects 6:34 Peptide Spotlight 11:48 Worth Knowing 12:30 Closing AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. If this episode was useful, a rating or a short review on Apple Podcasts or Spotify is how the next listener finds the show — and following it in your app means the next episode is there when you are. 📝 Full show notes, transcript & sources: read the episode page 🎧 Hear this show with the others you follow in one private morning episode, read to you by name. Try My Nerra free for 7 days, then $4.99 a month. 📬 The free Nerra Daily email, every morning at 7 AM Eastern: sign up 🌐 Part of the Nerra Network — explore every show at nerranetwork.com.
Ep 8: Six unapproved peptides can be compounded in US pharmacies without an FDA safety finding.
2026/11/05
Peptides Weekly Six unapproved peptides can be compounded in US pharmacies without an FDA safety finding. What You Need to Know: Six unapproved peptides can be compounded in US pharmacies without an FDA safety finding. Health and Human Services has said it will not enforce against licensed compounders of that set, even though the FDA's drug center opposed the idea. ... Sources: bioxconomy.com · demokratis.co.id · finance.yahoo.com · europepmc.org · bioprocessintl.com · boxinginsider.com Chapters: 0:00 Introduction 0:11 HHS Allows Pharmacies to Dispense Six Unapproved Peptides 0:22 HHS greenlights sale of six unapproved peptides despite FDA guidance 2:05 Oral semaglutide over 24 months in one Italian clinic 3:43 Peptide Spotlight 6:51 Worth Knowing 7:15 Closing AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. If this episode was useful, a rating or a short review on Apple Podcasts or Spotify is how the next listener finds the show — and following it in your app means the next episode is there when you are. 📝 Full show notes, transcript & sources: read the episode page 📬 Get the sources and notes by email, free: join the newsletter 🌐 Part of the Nerra Network — explore every show at nerranetwork.com.
Ep 7: A coroner links a 75-year-old's cardiac arrest to CJC-1295 and ipamorelin.
2026/10/29
Peptides Weekly A coroner links a 75-year-old's cardiac arrest to CJC-1295 and ipamorelin. What You Need to Know: A Victorian coroner has linked actor Richard Norton's cardiac arrest to two prescribed but unapproved peptides, CJC-1295 and ipamorelin, and asked Australia's regulator to reconsider whether doctors should be able to prescribe them. ... Sources: theguardian.com · abc.net.au · bbc.com · newsable.asianetnews.com · safemedicines.org · news.ssbcrack.com · statnews.com · firstwordpharma.com Chapters: 0:00 Introduction 0:22 A coroner links a 75-year-old's cardiac arrest to CJC-1295 and ipamorelin 1:47 US Health Secretary RFK Jr to expand access to unapproved peptides 3:57 Lilly's retatrutide bests Novo's Ozempic in head-to-head diabetes study 4:48 Hair Loss Associated With GLP-1 RAs Appear Similar by Race 5:03 Also Today 5:24 Peptide Spotlight 10:56 Worth Knowing 11:38 Closing AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. If this episode was useful, a rating or a short review on Apple Podcasts or Spotify is how the next listener finds the show — and following it in your app means the next episode is there when you are. 📝 Full show notes, transcript & sources: read the episode page 📬 Get the sources and notes by email, free: join the newsletter 🌐 Part of the Nerra Network — explore every show at nerranetwork.com.
Ep 6: Thirty-nine percent of GLP-1 users reported nail detachment, versus nine percent of controls.
2026/10/22
Peptides Weekly Thirty-nine percent of GLP-1 users reported nail detachment, versus nine percent of controls. What You Need to Know: In a cross-sectional comparison presented at a dermatology congress, thirty-nine percent of GLP-1 users reported nail detachment, versus nine percent of people who had never taken the drugs. A separate surgical-record analysis linked the same drug class to slightly lower odds of combined heart and infection problems after planned operations. ... Sources: labroots.com · yahoo.com · safemedicines.org · statnews.com · news-medical.net · eewmagazineonline.com · netimes.com.au Chapters: 0:00 Introduction 0:20 GLP-1 Drugs Linked to Nail and Hair Problems 4:17 A bipartisan group of lawmakers urges the FDA to close a peptide loophole 4:36 Semaglutide and teduglutide reduce immune-driven gut injury in mice 4:51 TikTok Blocks Peptide Searches 5:04 Peptide Spotlight 8:46 Worth Knowing 9:22 Closing AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. If this episode was useful, a rating or a short review on Apple Podcasts or Spotify is how the next listener finds the show — and following it in your app means the next episode is there when you are. 📝 Full show notes, transcript & sources: read the episode page 📬 Get the sources and notes by email, free: join the newsletter 🌐 Part of the Nerra Network — explore every show at nerranetwork.com.
Ep 5: Three to four extra rare vision-loss cases per ten thousand showed up in an observational…
2026/10/15
Peptides Weekly Three to four extra rare vision-loss cases per ten thousand showed up in an observational GLP-1 study. What You Need to Know: Three to four extra rare vision-loss cases per ten thousand showed up in an observational GLP-1 study. The link was seen in adults with type 2 diabetes and does not prove the drugs injured the optic nerve. ... Sources: ua.news · sciencedaily.com · biospace.com · medicaldaily.com · bipc.com · komu.com Chapters: 0:00 Introduction 0:15 The Week in Peptides 3:33 Peptide Spotlight 8:33 Worth Knowing 9:09 Closing AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. If this episode was useful, a rating or a short review on Apple Podcasts or Spotify is how the next listener finds the show — and following it in your app means the next episode is there when you are. 📝 Full show notes, transcript & sources: read the episode page 🌐 Part of the Nerra Network — explore every show at nerranetwork.com.
Ep 4: Unapproved peptides could reach temporary sale while treatment claims are still not fully…
2026/10/08
Peptides Weekly Unapproved peptides could reach temporary sale while treatment claims are still not fully safety tested. What You Need to Know: Unapproved peptides could reach temporary sale while treatment claims are still not fully safety tested. Political Wire, quoting The Washington Post, describes a drafting process for previously restricted peptides, not a completed approval and not a patient trial. ... Sources: washingtonpost.com · stocktwits.com · ascopost.com · amp.sacbee.com · foodnavigator.com Chapters: 0:00 Introduction 2:11 Peptide Spotlight 6:42 Worth Knowing 7:15 Closing AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. If this episode was useful, a rating or a short review on Apple Podcasts or Spotify is how the next listener finds the show — and following it in your app means the next episode is there when you are. 📝 Full show notes, transcript & sources: read the episode page 🌐 Part of the Nerra Network — explore every show at nerranetwork.com.
Ep 3: Nail detachment was over four times more common in people using GLP-1 drugs.
2026/10/01
Peptides Weekly Nail detachment was over four times more common in people using GLP-1 drugs. What You Need to Know: A controlled study found nail detachment more than four times as often among people using GLP-1 drugs. The same week brought a muscle-loss trial beside semaglutide, a randomized look at how semaglutide meets the kidney, and two reminders that a population trend and a protein-design paper are not treatment results. ... Sources: medicalxpress.com · reuters.com · nature.com · t.co Chapters: 0:00 Introduction 2:37 Peptide Spotlight 8:05 Worth Knowing 8:43 Closing AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. 📝 Full show notes, transcript & sources: read the episode page 🌐 Part of the Nerra Network — explore every show at nerranetwork.com.
Ep 2: Nearly one in six children taking GLP-1 drugs show nutritional deficiencies in a new study.
2026/09/24
Peptides Weekly Nearly one in six children taking GLP-1 drugs show nutritional deficiencies in a new study. What You Need to Know: A retrospective analysis found nutritional deficiencies in almost 17 percent of children prescribed GLP-1 receptor agonists for weight loss or diabetes. The finding comes from claims data and highlights a measurable gap in monitoring for younger patients. ... Sources: sciencedaily.com · yaledailynews.com · euractiv.com · velo.outsideonline.com · sciencedirect.com · europepmc.org Chapters: 0:00 Intro 0:10 Introduction 3:27 Peptide Spotlight 5:39 Worth Knowing 6:22 Closing AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. 📝 Full show notes, transcript & sources: read the episode page 🌐 Part of the Nerra Network — explore every show at nerranetwork.com.
Ep 1: Phase 3 results for an investigational amylin peptide medicine in diabetes and obesity were…
2026/09/23
Peptides Weekly Phase 3 results for an investigational amylin peptide medicine in diabetes and obesity were released this week. What You Need to Know: Novo Nordisk reported new phase 3 data on an amylin-based candidate. A pair of randomized trials found oral semaglutide did not slow progression in mild Alzheimer’s disease. ... Chapters: 0:00 Intro 0:11 Introduction 2:11 An animal study measured neurotensin signaling and gut… 3:34 Peptide Spotlight 5:57 Closing AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. 📝 Full show notes, transcript & sources: read the episode page 🌐 Part of the Nerra Network — explore every show at nerranetwork.com.

Podcast reviews

Read Peptides Weekly podcast reviews


0 out of 5
0 reviews

Podcast sponsorship advertising

Start advertising on Peptides Weekly relevant audience podcasts


What do you want to promote?